Anti-CRISPR-Cas9 antibody [7A9-3A3]
4
(11 Reviews)
|
(79 Publications)
Anti-CRISPR-Cas9 antibody [7A9-3A3] (ab191468) is a mouse monoclonal antibody detecting CRISPR-Cas9 in Western Blot, ICC/IF.
- Over 50 publications
View Alternative Names
csn1, cas9, CRISPR-associated endonuclease Cas9, St-Cas9
- ICC/IF
Lab
Immunocytochemistry/ Immunofluorescence - Anti-CRISPR-Cas9 antibody [7A9-3A3] (AB191468)
ab191468 stained in NIH3T3 cells. Untreated and Cas9 transfected cells were fixed with 4% paraformaldehyde (10min) at room temperature and incubated with PBS containing 10% goat serum, 0.3 M glycine, 1% BSA and 0.1% triton for 1h at room temperature to permeabilise the cells and block non-specific protein-protein interactions. The cells were then incubated with the antibody ab191468 at 10μg/ml and ab6046 (Rabbit polyclonal to beta tubulin) at 1ug/ml overnight at +4°C. The secondary antibodies were ab150117 (colored green) used at 1 ug/ml and ab150087 (pseudo-colored red) used at 2ug/ml for 1hour at room temperature. DAPI was used to stain the cell nuclei (colored blue) at a concentration of 1.43μM for 1hour at room temperature.
- WB
AbReview66778****
Western blot - Anti-CRISPR-Cas9 antibody [7A9-3A3] (AB191468)
Lane 1 : HeLa inducible Cas9 cell line in the absence of Doxcycline (-DOX)
Lane 2 : HeLa inducible Cas9 cell line in the treated for 24 hours in the presence of 1ug/ml of Doxcycline (+DOX).
Blot was probed with Anti-CRISPR-Cas9 antibody [7A9-3A3] (ab191468) 1 : 2000 and Anti-Tubulin Antibody DM1A (Sigma) as loading control. Shows specific band at 170kDA in Dox treated cells and tubulin band at 50kDa. Lysis and running Cells lysed in 1.5X Lammeli buffer +0.15M DTT syringed 10X with 25g needle and then boiled 100 degrees C for 10 minutes. 10ug of sample run out on 4-12% Bis Tris Nupage gel in 1X MOPS buffer WB protocol Western blot was performed by wet transfer of gel onto nitrocellulose membrane 100V for 2 h 4 degrees. Blocked in 5% milk PBST for 1 h room temp (1X PBS + 0.1% tween 20) incubated 24h at 4 degrees in 5% PBST with primary antibodies 1 : 2000 Anti-CRISPR-Cas9 antibody [7A9-3A3] (ab191468) as well as 1 : 3000 Anti Tubulin Mouse monoclonal DM1A antibody ( Sigma) Washed 3X PBST IgG anti mouse HRP 1 : 5000 (Jackson immunoscience) Washed 3x PBST Washed
HeLa cell line contains Cas9 under the control of a Doxcycline/Tetracycline inducible promotor (Tet on) Specific band at 170 kDa appears upon treatment with Doxcycline 1ug/ml for 24hours.1X PBS Developed using ECL prime kit (GE healthcare).
All lanes:
Western blot - Anti-CRISPR-Cas9 antibody [7A9-3A3] (ab191468)
Predicted band size: 160 kDa
false
This image was courtesy of an anonymous AbReview
- WB
Lab
Western blot - Anti-CRISPR-Cas9 antibody [7A9-3A3] (AB191468)
Gel type : MOPS
Blocking buffer : 3% milk block
All lanes:
Western blot - Anti-CRISPR-Cas9 antibody [7A9-3A3] (ab191468) at 5 µg/mL
Lane 1:
NIH 3T3 whole cell lysate at 20 µg
Lane 2:
NIH 3T3 overexpressing Cas9 whole cell lysate at 20 µg
Secondary
All lanes:
Goat polyclonal to Mouse IgG - H&L - Pre-Adsorbed (HRP) at 1/5000 dilution
Predicted band size: 160 kDa
Observed band size: 160 kDa
false
Exposure time: 4min
- WB
Lab
Western blot - Anti-CRISPR-Cas9 antibody [7A9-3A3] (AB191468)
We recommend using 3% milk as the blocking agent in Western Blot.
All lanes:
Western blot - Anti-CRISPR-Cas9 antibody [7A9-3A3] (ab191468) at 5 µg/mL
Lane 1:
S2 non-transfected cell lysate at 20 µg
Lane 2:
S2 cells transfected with CRISPR-Cas9 plasmid at 20 µg
Secondary
All lanes:
Goat polyclonal to Mouse IgG - H&L - Pre-Adsorbed (HRP) at 1/5000 dilution
Predicted band size: 160 kDa
Observed band size: 160 kDa
true
Exposure time: 4min
Related conjugates and formulations (1)
-
HRP Anti-CRISPR-Cas9 antibody [7A9-3A3]
Reactivity data
Product details
Anti-CRISPR-Cas9 antibody [7A9-3A3] (ab191468) is a House Mouse Monoclonal antibody and is validated for use in ICC/IF, WB in human, mouse, pig, rabbit, rat samples.
Anti-CRISPR-Cas9 antibody [7A9-3A3] (ab191468) has been cited over 55 times in peer reviewed journals and is trusted by the scientific community.
Abcams high quality validation processes ensure Anti-CRISPR-Cas9 antibody [7A9-3A3] (ab191468) has high sensitivity and specificity.
Anti-CRISPR-Cas9 antibody [7A9-3A3] (ab191468) has 11 independent reviews from customers.
Anti-CRISPR-Cas9 antibody [7A9-3A3] (ab191468) specifically detects CRISPR-Cas9 (UniProt ID: Q99ZW2; Molecular weight: 158kDa) and is sold in 100 ug selling sizes.
Antibody clone 7A9-3A3 is also available pre-conjugated to a variety of labels for your convenience - HRP (ab2258).
CRISPR-Cas9 technology enables precise gene editing to enhance cancer immunotherapy. It allows for the modification of immune cells to better target and destroy cancer cells, improving the efficacy of treatments like CAR-T cell therapy. Additionally, CRISPR-Cas9 can be used to identify and target immune checkpoint molecules, overcoming immune evasion by tumors.
Want a custom formulation?
This antibody clone is manufactured by Abcam. If you require a custom buffer formulation or conjugation for your experiments, please contact orders@abcam.com
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
The Cas9 protein functions as an integral part of the CRISPR-Cas9 complex which includes a guide RNA to direct the protein to specific DNA sequences. This complex enables precise cuts at targeted locations within the genome. The Cas9 protein size allows it to fit effectively within cells facilitating genome editing in areas such as research agriculture and therapeutics. The complexity of CRISPR-Cas9 also includes the interaction with other cellular components that assist in DNA repair post-cleavage.
Pathways
CRISPR-Cas9 plays a role in DNA repair pathways particularly non-homologous end joining and homologous recombination. After Cas9-induced DNA breaks these pathways become active to repair the cleaved DNA. The gene editing process facilitated by CRISPR-Cas9 often involves interaction with DNA repair proteins like ku70/80 and Rad51 in response to induced breaks. This allows for either the incorporation of new genetic material or the modification of existing genes.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (79)
Recent publications for all applications. Explore the full list and refine your search
Nature communications 16:8716 PubMed41028718
2025
Applications
Unspecified application
Species
Unspecified reactive species
Acta neuropathologica communications 13:164 PubMed40721826
2025
Applications
Unspecified application
Species
Unspecified reactive species
Cancer cell international 25:272 PubMed40684193
2025
Applications
Unspecified application
Species
Unspecified reactive species
RNA biology 22:1-15 PubMed40421600
2025
Applications
Unspecified application
Species
Unspecified reactive species
Cancer research 85:2890-2904 PubMed40327605
2025
Applications
Unspecified application
Species
Unspecified reactive species
Cancer gene therapy 32:437-449 PubMed40089636
2025
Applications
Unspecified application
Species
Unspecified reactive species
BMC genomics 26:217 PubMed40045211
2025
Applications
Unspecified application
Species
Unspecified reactive species
PLoS pathogens 21:e1012531 PubMed39792924
2025
Applications
Unspecified application
Species
Unspecified reactive species
Proceedings of the National Academy of Sciences of the United States of America 121:e2413298121 PubMed39585990
2024
Applications
Unspecified application
Species
Unspecified reactive species
Nature protocols 20:1158-1195 PubMed39487259
2024
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com